Cantor Fitzgerald Downgrades Tonix Pharma (TNXP) to Hold
Tweet
Share
E-mailGet Alerts TNXP Hot Sheet
Price: $0.16 --0%
Rating Summary:
4 Buy, 4 Hold, 0 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 11 | Down: 8 | New: 12
Rating Summary:
4 Buy, 4 Hold, 0 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 11 | Down: 8 | New: 12
Join SI Premium – FREE
Cantor Fitzgerald downgraded Tonix Pharma (NASDAQ: TNXP) from Buy to Hold with a price target of $1.00 (from $5.00).
For an analyst ratings summary and ratings history on Tonix Pharma click here. For more ratings news on Tonix Pharma click here.
Shares of Tonix Pharma closed at $0.92 yesterday.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- RBC Capital Upgrades Galp Energia SGPS SA (GALP:LI) (GLPEF) to Outperform
- Munich Re (MUV2:GR) (MURGY) PT Raised to EUR464 at RBC Capital
- Texas Instruments (TXN) PT Raised to $175 at Baird
Create E-mail Alert Related Categories
Analyst PT Change, DowngradesRelated Entities
Cantor FitzgeraldSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
